20:26 , Oct 31, 2018 |  BC Innovations  |  Distillery Therapeutics

Ophthalmic disease

INDICATION: Blindness Mouse studies identified a LIF-based fusion protein that could help treat blindness. The fusion protein consists of human LIF fused to bacterial dihydrofolate reductase (DHFR), which is stabilized by the antibiotic Primsol trimethoprim....
07:00 , Apr 11, 2016 |  BC Week In Review  |  Company News

Aytu, Allegis deal

Aytu granted Allegis exclusive rights to co-promote Primsol trimethoprim in the U.S. Allegis will promote the drug to pediatricians; Aytu retains all other rights. Primsol, a liquid formulation of antibiotic trimethoprim, is approved in the...